FindTrial
Sign In

Matrix induced Autologous Chondrocyte Implantation

Matrix induced Autologous Chondrocyte Implantation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016417
Enrollment
Unknown
Registered
2018-06-01
Start date
2017-07-01
Completion date
Unknown
Last updated
2018-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee or sacroiliac joint cartilage injury

Interventions

Case series:none

Sponsors

Shanghai Changzheng Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Complete contralateral articular cartilage (up to ICRS Level II); 2. Complete Meniscus (2/3 complete); 3. Intact ligament (if incomplete: rebuild required); 4. Defect size < 10 cm2; 5. Correct leg axis (Offset up to 4 degree, corrected also available); 6. Freedom Movement; 7. Body mass index < 30; 8. < 50 years old; 9. Closed jaw.

Exclusion criteria

Exclusion criteria: 1. Joint infection; 2. OA (osteoarthritis), RA (rheumatoid arthritis); 3. HIV, Hepatitis B; 4. Other systems. Diseases (Lupus, etc.).

Design outcomes

Primary

MeasureTime frame
Lysholm Knee Score Sheet;—

Countries

China

Contacts

Public ContactFu Peiliang

Shanghai Changzheng Hospital

fupeiliang@163.com+86 13636377844

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026